Carbamazepine Treatment for Cocaine Dependence - 5
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00000191 |
Recruitment Status :
Completed
First Posted : September 21, 1999
Last Update Posted : May 28, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cocaine-Related Disorders | Drug: Carbamazepine | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 0 participants |
Primary Purpose: | Treatment |
Official Title: | Carbamazepine Treatment for Cocaine Dependence |
Study Start Date : | January 1991 |
Actual Primary Completion Date : | February 1994 |
Actual Study Completion Date : | February 1994 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years to 51 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00000191
United States, Pennsylvania | |
University of Pennsylvania | |
Philadelphia, Pennsylvania, United States, 19104 6178 |
Principal Investigator: | James Cornish, M.D. | University of Pennsylvania |
Responsible Party: | James Cornish, Principal Investigator, University of Pennsylvania |
ClinicalTrials.gov Identifier: | NCT00000191 |
Other Study ID Numbers: |
NIDA-00144-5 3R01DA012268 ( U.S. NIH Grant/Contract ) K20-00144-5 |
First Posted: | September 21, 1999 Key Record Dates |
Last Update Posted: | May 28, 2015 |
Last Verified: | May 2015 |
Cocaine Dependence Carbamazepine |
Cocaine-Related Disorders Substance-Related Disorders Chemically-Induced Disorders Mental Disorders Carbamazepine Anticonvulsants Antimanic Agents Tranquilizing Agents Central Nervous System Depressants Physiological Effects of Drugs |
Psychotropic Drugs Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Sodium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Cytochrome P-450 CYP3A Inducers Cytochrome P-450 Enzyme Inducers |